Tower Research Capital LLC (Trc) Eli Lilly & CO Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Eli Lilly & CO stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,259 shares of LLY stock, worth $15.2 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

20,259

Previous 28,016 27.69%

Holding current value

$15.2 Million

Previous $25.4 Million 29.24%

% of portfolio

0.49%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $5.99 Million - $7.45 Million	-7,757 Reduced 27.69%	20,259 $17.9 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $5.55 Million - $6.96 Million	7,651 Added 37.57%	28,016 $25.4 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $51.7 Million - $69.1 Million	-87,258 Reduced 81.08%	20,365 $15.8 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $40 Million - $47.2 Million	76,160 Added 242.06%	107,623 $62.7 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $6.29 Million - $8.67 Million	14,467 Added 85.12%	31,463 $16.9 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.02 Million - $1.37 Million	2,920 Added 20.74%	16,996 $7.97 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $863,551 - $1.01 Million	-2,780 Reduced 16.49%	14,076 $4.83 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $17.3 Million - $20.2 Million	-53,808 Reduced 76.15%	16,856 $6.17 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $9.49 Million - $10.8 Million	32,000 Added 82.76%	70,664 $22.8 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $18.7 Million - $21.9 Million	-67,003 Reduced 63.41%	38,664 $12.5 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $14.2 Million - $17.6 Million	60,377 Added 133.31%	105,667 $30.3 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $6.84 Million - $8.49 Million	30,412 Added 204.41%	45,290 $12.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $758,315 - $933,213	-3,422 Reduced 18.7%	14,878 $3.44 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $11.8 Million - $15.3 Million	-65,550 Reduced 78.18%	18,300 $4.2 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $9.29 Million - $12 Million	56,515 Added 206.75%	83,850 $15.7 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $1.75 Million - $2.31 Million	13,388 Added 95.99%	27,335 $4.62 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $184,529 - $213,442	1,262 Added 9.95%	13,947 $2.06 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $1.62 Million - $1.95 Million	11,885 Added 1485.63%	12,685 $2.08 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $85,596 - $105,944	-719 Reduced 47.33%	800 $111,000
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $1.21 Million - $1.49 Million	-11,276 Reduced 88.13%	1,519 $200,000
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $1.37 Million - $1.49 Million	12,795 New	12,795 $1.43 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $1.46 Million - $1.71 Million	-13,192 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $1.91 Million - $2.25 Million	-17,170 Reduced 56.55%	13,192 $1.71 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2.27 Million - $2.54 Million	21,430 Added 239.92%	30,362 $3.51 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $1.76 Million - $2.2 Million	-20,513 Reduced 69.67%	8,932 $958,000
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $2.23 Million - $2.56 Million	29,445 New	29,445 $2.51 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $229,383 - $270,771	-3,091 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $217,550 - $233,347	2,655 Added 608.94%	3,091 $261,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $33,602 - $37,295	436	436 $37,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Eli Lilly & CO Transaction History